sulforaphane has been researched along with Liver Diseases in 5 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to investigate the effect of Sulforaphane on ischemia/ reperfusion (IR) injury of the liver and distant organs resulting from liver blood flow arrest." | 7.81 | The effects of sulforaphane on the liver and remote organ damage in hepatic ischemia-reperfusion model formed with pringle maneuver in rats. ( Alabalik, U; Kapan, M; Kaplan, I; Oguz, A; Polat, Y; Turkoglu, A; Ulger, BV; Uslukaya, O, 2015) |
| "Sulforaphane (SFN) is a dietary isothiocyanate that exerts chemopreventive effects via NF-E2-related factor 2 (Nrf2)-mediated induction of antioxidant/phase II enzymes, such as heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1)." | 5.38 | Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. ( Harris, RA; Kim, HJ; Kim, JY; Lee, IK; Min, AK; Oh, CJ; Park, KG, 2012) |
| "The purpose of this study was to determine the effect of sulforaphane (SFN) on hepatic ischemia reperfusion injury (HIRI) and to explore the underlying mechanisms." | 3.81 | Sulforaphane reduces apoptosis and oncosis along with protecting liver injury-induced ischemic reperfusion by activating the Nrf2/ARE pathway. ( Alina, A; Chi, X; Jin, Y; Lin, S; Shen, N; Yang, S; Zhang, R, 2015) |
| "The purpose of this study was to investigate the effect of Sulforaphane on ischemia/ reperfusion (IR) injury of the liver and distant organs resulting from liver blood flow arrest." | 3.81 | The effects of sulforaphane on the liver and remote organ damage in hepatic ischemia-reperfusion model formed with pringle maneuver in rats. ( Alabalik, U; Kapan, M; Kaplan, I; Oguz, A; Polat, Y; Turkoglu, A; Ulger, BV; Uslukaya, O, 2015) |
| "Sulforaphane (SFN) is a dietary isothiocyanate that exerts chemopreventive effects via NF-E2-related factor 2 (Nrf2)-mediated induction of antioxidant/phase II enzymes, such as heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1)." | 1.38 | Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. ( Harris, RA; Kim, HJ; Kim, JY; Lee, IK; Min, AK; Oh, CJ; Park, KG, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, J | 1 |
| Guo, X | 1 |
| Li, T | 1 |
| Xie, Y | 1 |
| Wang, D | 1 |
| Yi, L | 1 |
| Mi, M | 1 |
| Panda, H | 1 |
| Keleku-Lukwete, N | 1 |
| Kuga, A | 1 |
| Fuke, N | 1 |
| Suganuma, H | 1 |
| Suzuki, M | 1 |
| Yamamoto, M | 1 |
| Chi, X | 1 |
| Zhang, R | 1 |
| Shen, N | 1 |
| Jin, Y | 1 |
| Alina, A | 1 |
| Yang, S | 1 |
| Lin, S | 1 |
| Oguz, A | 1 |
| Kapan, M | 1 |
| Kaplan, I | 1 |
| Alabalik, U | 1 |
| Ulger, BV | 1 |
| Uslukaya, O | 1 |
| Turkoglu, A | 1 |
| Polat, Y | 1 |
| Oh, CJ | 1 |
| Kim, JY | 1 |
| Min, AK | 1 |
| Park, KG | 1 |
| Harris, RA | 1 |
| Kim, HJ | 1 |
| Lee, IK | 1 |
5 other studies available for sulforaphane and Liver Diseases
| Article | Year |
|---|---|
Sulforaphane Inhibits Exhaustive Exercise-Induced Liver Injury and Transcriptome-Based Mechanism Analysis.
Topics: Animals; Exercise; Glucose; Isothiocyanates; Lipids; Liver; Liver Diseases; Mice; Mice, Inbred C57BL | 2023 |
Dietary supplementation with sulforaphane attenuates liver damage and heme overload in a sickle cell disease murine model.
Topics: Anemia, Sickle Cell; Animals; Dietary Supplements; Disease Models, Animal; Female; Heme; Humans; Iso | 2019 |
Sulforaphane reduces apoptosis and oncosis along with protecting liver injury-induced ischemic reperfusion by activating the Nrf2/ARE pathway.
Topics: Alanine Transaminase; Animals; Anticarcinogenic Agents; Apoptosis; Aspartate Aminotransferases; Calc | 2015 |
The effects of sulforaphane on the liver and remote organ damage in hepatic ischemia-reperfusion model formed with pringle maneuver in rats.
Topics: Animals; Anticarcinogenic Agents; Disease Models, Animal; Drug Administration Schedule; Ischemia; Is | 2015 |
Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
Topics: Active Transport, Cell Nucleus; Animals; Cell Line; Enzyme Induction; Extracellular Matrix Proteins; | 2012 |